Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

CNS 3Breast 1

Conditions

Central Nervous System Neoplasms 2Central Nervous System Diseases 2Breast Neoplasms 1Brain Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × gadobenic acid × Clear all
NCT00395863 2020-11-05

Multihance at 3 Tesla (3T) in Brain Tumors

Bracco Diagnostics, Inc

Phase 4 Completed
46 enrolled 18 charts
CNS

Brain Neoplasms

NCT03147989 2018-07-18

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Bracco Diagnostics, Inc

Completed
352 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT02291822 2016-07-19

Retrospective Study of MRI in Pediatric Patients

Bracco Diagnostics, Inc

Completed
90 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT00486473 2010-07-15

DETECT

Bracco Diagnostics, Inc

Phase 3 Completed
130 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡